A detailed history of Parallel Advisors, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 344 shares of LNTH stock, worth $31,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares
344
Previous 294 17.01%
Holding current value
$31,297
Previous $23,000 60.87%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$77.7 - $123.62 $3,885 - $6,181
50 Added 17.01%
344 $37,000
Q2 2024

Aug 08, 2024

BUY
$58.87 - $83.05 $824 - $1,162
14 Added 5.0%
294 $23,000
Q1 2024

May 06, 2024

BUY
$51.07 - $68.26 $12,920 - $17,269
253 Added 937.04%
280 $17,000
Q4 2023

Feb 09, 2024

SELL
$55.6 - $77.89 $3,614 - $5,062
-65 Reduced 70.65%
27 $1,000
Q3 2023

May 20, 2024

BUY
$60.27 - $90.75 $3,435 - $5,172
57 Added 162.86%
92 $6,000
Q3 2023

Nov 13, 2023

BUY
$60.27 - $90.75 $3,435 - $5,172
57 Added 162.86%
92 $6,000
Q2 2023

May 20, 2024

BUY
$82.41 - $99.65 $82 - $99
1 Added 2.94%
35 $2,000
Q2 2023

Aug 04, 2023

BUY
$82.41 - $99.65 $82 - $99
1 Added 2.94%
35 $2,000
Q1 2023

May 20, 2024

SELL
$47.76 - $82.86 $11,748 - $20,383
-246 Reduced 87.86%
34 $2,000
Q1 2023

Apr 25, 2023

SELL
$47.76 - $82.86 $1,958 - $3,397
-41 Reduced 54.67%
34 $2,000
Q4 2022

Feb 03, 2023

BUY
$48.76 - $77.67 $438 - $699
9 Added 13.64%
75 $3,000
Q3 2022

Nov 10, 2022

BUY
$61.42 - $86.29 $2,641 - $3,710
43 Added 186.96%
66 $5,000
Q2 2022

Aug 01, 2022

BUY
$55.54 - $72.65 $833 - $1,089
15 Added 187.5%
23 $2,000
Q1 2022

Apr 28, 2022

SELL
$24.28 - $56.64 $1,553 - $3,624
-64 Reduced 88.89%
8 $0
Q4 2021

Jan 20, 2022

BUY
$22.54 - $30.44 $1,622 - $2,191
72 New
72 $2,000
Q4 2019

Jan 30, 2020

SELL
$18.47 - $24.03 $923 - $1,201
-50 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$23.33 - $28.3 $1,166 - $1,415
50 New
50 $1,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.25B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.